May 20, 2017

In May, Clinical Leader Chief Editor Ed Miseta sat down with our President and CEO Ibraheem “Ibs” Mahmood, and with Dr. Michael Snape, CEO and CSO of AMO Pharma to discuss how technology can help biotech improve the search for treatments for debilitating disorders including rare genetic disorders.